Target intelligence / Profile preview

General transcriptional coactivator and basal transcription machinery complexes

Molecular classification
Transcription factor, Enzyme, Protein complex, Coactivator
01

Overview

The general transcriptional coactivator and basal transcription machinery complexes represent the core protein assembly required for the transcription of protein-coding genes by RNA polymerase II. This group encompasses the RNA polymerase II enzyme itself, the general transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH), and essential coactivators like the Mediator complex and p300/CBP. These components assemble at gene promoters to form the pre-initiation complex (PIC), which is responsible for DNA unwinding, transcription initiation, and the transition to elongation. In many pathological states, particularly in oncology, these complexes are dysregulated or exploited by oncogenic drivers to maintain high levels of gene expression, a phenomenon known as transcriptional addiction. Therapeutic targeting of this machinery typically involves small-molecule inhibitors of associated kinases, such as CDK7 and CDK9, or direct inhibitors of RNA polymerase II. While these agents show promise in treating aggressive cancers and certain viral infections, their development is often limited by a narrow therapeutic window due to the essential role of these complexes in normal cellular homeostasis.

Other names
RNA polymerase II pre-initiation complexBasal transcription factorsTranscriptional co-regulatorsGTF-coactivator complexesRNA polymerase II transcription machinery
02

Mechanism of action

Inhibition of RNA polymerase II C-terminal domain (CTD) phosphorylation, disruption of the pre-initiation complex, and inhibition of transcriptional elongation.

03

Biological functions

Transcription initiationRNA synthesisGene expression regulationTranscriptional elongation
04

Disease associations

CancerInfectionGenetic disorder
05

Safety considerations

General cytotoxicityNeutropeniaGastrointestinal distressNarrow therapeutic window
06

Interacting drugs

Alvocidib

6 more in the full profile.

07

Biomarkers

MYC amplificationMCL1 expressionRNA polymerase II phosphorylation status

Beyond the preview

Go deeper on General transcriptional coactivator and basal transcription machinery complexes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcriptional coactivator and basal transcription machinery complexes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call